-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-executive-summary.pdf
May 01, 2025 - Multi-
cancer early detection test sensitivity for
cancers with and without current population-
level … Neoplasia. Dec
2023;46:100941.
doi:10.1016/j.neo.2023.100941
12. … Integrative
modeling of tumor genomes and
epigenomes for enhanced cancer diagnosis
by cell-free DNA … TOTEM: a
multi-cancer detection and localization
approach using circulating tumor DNA
methylation … Prospective validation study: a non-invasive
circulating tumor DNA-based assay for
simultaneous early
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
October 01, 2015 - These
include the stage of the cancer, tumor grade (higher grade
tumors are more likely to recur and … progress), whether the
tumor is an initial tumor or a recurrence, number and size
of tumors, and patient … tumors (SOE: high) … versus smaller
tumors (SOE: low) … 1 cm or >2 cm) vs. smaller tumors.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lung-cancer-nonsurgical-therapies_executive.pdf
June 01, 2013 - size, and tumor
location … ablation, rather than tumor cell kill, allowing
for little to no tumor cell repopulation between doses … Stereotactic
ablative radiation therapy for primary lung tumors. … A systematic review of
radiofrequency ablation for lung tumors. … Image-guided thermal ablation of lung malignancies.
Radiology. 2011 Sep;260(3):633-55.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_research-protocol.pdf
December 17, 2013 - assess stage
Comparator Comparison of multiple imaging modalities
No comparator
None
Outcomes Tumor … Found
1 exp Diagnostic Imaging 1737346
2 exp Breast Neoplasms/dh, dt, pc, rt, su, th [Diet … Therapy,
Drug Therapy, Prevention & Control, Radiotherapy, Surgery,
Therapy]
101054
3 exp Neoplasm … exp survival analysis/ 190795
11 6 or 7 1163519
12 1 and 2 and 5 and 11 632
13 exp *Breast Neoplasms … characteristics Type(s) of imaging described
Comparator Type(s) of comparators, if any
Outcomes measured Tumor
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/head-neck-cancer-update_consumer.pdf
August 01, 2015 - � Radiation therapy: High-energy radiation beams are used to kill
cancer cells in and around the tumor … Radiation therapy uses high-energy radiation beams to kill cancer
cells in and around a tumor. … � It can shrink tumors, reduce some symptoms, and relieve pain. … that hits healthy tissues
around the tumor. … The goal is to:
� Target the tumor with the right amount (dose) of radiation
� Limit the radiation
-
effectivehealthcare.ahrq.gov/health-topics/cancer-children
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_disposition-comments.pdf
December 16, 2014 - PIVOT
conducted in the US and primarily involved men with PSA detected tumors. … Nearly 80% of SPCG-4
subjects had T2 (palpable) tumors vs. only about 45% in PIVOT.
P 59. … The report focuses only on T1 through T3a
cancers. … ,
Reduces the risk of a second malignant neoplasms (SMN) in prostate
patients compared with contemporary … Risk
of secondary malignant neoplasms from
proton therapy and intensity-modulated x-
ray therapy for
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-nonsurgical-therapies_research-protocol.pdf
February 22, 2012 - and Endobronchial Obstruction Due to Advanced Lung Tumors
I. … recurrence, noncancer-related mortality, and second malignancies.2, 3
Malignant Endobronchial Obstruction … Intraoperative seed placement for thoracic
malignancy-A review of technique, indications, and published … '/exp OR ('lung neoplasms'/exp OR 'lung cancer'/exp AND ('non-
small-cell' OR 'non-small cell' OR 'non … '/exp OR ('lung neoplasms'/exp OR 'lung cancer'/exp AND ('non-
small-cell' OR 'non-small cell' OR 'non
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_executive.pdf
April 01, 2013 - leading cause of cancer deaths in men
in the United States.1,2 Most patients
have slow-growing tumors … lifetime risk of dying from the disease
is only 3 percent.1,3,5 However, some
patients have aggressive tumors … effectiveness of using PCA3 testing alone, or
in combination with the standard prognostic workup
(e.g., tumor … PCA3 score before radical
prostatectomy predicts extracapsular extension and tumor volume. … PCA3 molecular
urine assay correlates with prostate cancer tumor volume:
implication in selecting candidates
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-supplementary-app-i.xlsx
January 01, 2019 - meta-analysis supports existence of effect modification for immunotherapy by PD-L1 status in gastric cancer … Multiple other effect modifiers evaluated.
41436 MAGIC Primary tumor location Yes Overall survival Hazard … Multiple other effect modifiers evaluated.
47286 KEYNOTE-585 Primary tumor location Yes Overall survival … evaluating the correlation between TUBB3 expression and taxane-based chemotherapy for gastric and other cancers … Cut point for dichotomization of unclear clinical relevance.
43481 JACCRO GC-07 Tumor location within
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-apbi-breast-cancer.pdf
August 01, 2022 - patients with early stage breast cancer reduces tumor
recurrence and increases survival.4 According … cancer stage, tumor size,
tumor margin status,
estrogen receptor status, etc. … Comparison of Treatment Costs for Breast Cancer, by Tumor
Stage and Type of Service. … syndrome"/ or inflammatory breast neoplasms/
or triple negative breast neoplasms/ or unilateral breast … neoplasms/ (295124)
2 (breast adj5 (cancer* or carcinoma* or invasive or malignan* or noninvasive or
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendix-c-prepub-final.xlsx
January 01, 2025 - Neoplasia. 2023 Dec;46:100941. doi: 10.1016/j.neo.2023.100941. PMID: 37918207. … Validation cohort ("V") included 82 participants with GI cancers, 11 participants with benign tumors, … The diagnostic performance of the tumor markers for GI cancer screening (analysis 1) and whole-body cancer … Staging per TNM Classification of Malignant Tumors by Union for International Cancer Control, 8th ed. … Both new and recurrent: 1/35
Solid tumors: 19/35 (53%)
Hematologic: 17/35 (47%)
TP with new cancer:
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-final-app-c.xlsx
January 01, 2025 - Neoplasia. 2023 Dec;46:100941. doi: 10.1016/j.neo.2023.100941. PMID: 37918207. … Validation cohort ("V") included 82 participants with GI cancers, 11 participants with benign tumors, … The diagnostic performance of the tumor markers for GI cancer screening (analysis 1) and whole-body cancer … Staging per TNM Classification of Malignant Tumors by Union for International Cancer Control, 8th ed. … Both new and recurrent: 1/35
Solid tumors: 19/35 (53%)
Hematologic: 17/35 (47%)
TP with new cancer:
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-liver-metastases-therapies_executive.pdf
December 01, 2012 - Most colorectal cancers are
adenocarcinomas, meaning that they are
a cancer of the epithelium originating … Is extended
hepatectomy for hepatobiliary malignancy justified? … Extended hepatectomy
in patients with hepatobiliary malignancies with and without
preoperative portal … HIF1A overexpression is
associated with poor prognosis in a cohort of 731 colorectal
cancers. … Recommendations for
radioembolization of hepatic malignancies using Yttrium-90
microsphere brachytherapy
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-liver-metastases-therapies_research-protocol.pdf
September 27, 2012 - die with hepatic metastases.1 Colorectal cancer is the most
common malignancy that metastasizes to … "[Mesh] OR ((hepatic OR liver) AND (cancer OR cancers OR oncology
OR neoplasms)) AND "Colorectal Neoplasms … OR cancers OR oncology OR neoplasms AND
colon OR colorectal OR rectal OR intestinal OR rectum OR intestine … Is Extended Hepatectomy for Hepatobiliary
Malignancy Justified? Ann Surg 2004;239(5):722-32. … Antiangiogenic agents in advanced gastrointestinal
malignancies: past, present and a novel future.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_surveillance.pdf
August 01, 2012 - oral or paranasal or para-nasal or nasal or sinus or salivary or parotid).ti,ab. (1428510)
3 (neoplasm … or neoplasms or tumor or tumors or tumour or tumours or cancer or cancers or
adenocarcinoma or carcinoma … oral or paranasal or para-nasal or nasal or sinus or salivary or parotid).ti,ab. (1428510)
39 (neoplasm … or neoplasms or tumor or tumors or tumour or tumours or cancer or cancers or
adenocarcinoma or carcinoma … or neoplasms or tumor or tumors or tumour or tumours or cancer or
cancers or adenocarcinoma or carcinoma
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-radiation_executive.pdf
November 01, 2009 - (e.g.,
lung, prostate, breast) and uncommon cancers (e.g.,
skull base tumors, uveal melanomas). … survival (e.g., disease-free survival, progression-free survival, tumor response rate, or quality of … Three trials pertained to prostate
cancer, whereas the remaining dealt with less common
cancers (ocular … melanoma, skull base and brain tumors,
and pancreatic cancer). … Especially for many common cancers, such as breast,
prostate, lung, and pancreatic cancers, it is essential
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_clinician.pdf
January 01, 2016 - includes tumors confined
to the prostate (T1–T2) and tumors with extracapsular
extension but without … be influenced
by factors such as patient age and health at the time of
diagnosis, life expectancy, tumor … therapy (e.g., androgen deprivation therapy [ADT])
Interstitial brachytherapy: a strategy whereby tumor … –� Recommended treatment options based on the patient’s
age, health status, life expectancy, and tumor … stage
–� The potential for tumor eradication with treatment
–� Available evidence for the efficacy and
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiation-therapy-brain-metases-protocol.pdf
October 10, 2019 - studies have
shown that prognosis can vary substantially.5-8 Brain metastases occur with a variety of
cancers … While treatment for brain metastases from other primary cancers
and in pediatric patients is equally … Epidemiology of metastatic brain tumors. … Effect of tumor subtype on survival and the
graded prognostic assessment for patients with breast cancer … OR cancer* OR neoplasm* OR
carcinoma* OR metastasectomy)))
AND
(MH "Radiosurgery") OR TI(radiation
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-screening_research-protocol.pdf
May 18, 2011 - For advanced neoplasia. … Gastroenterology, American Society of Clinical
Oncology, Digestive Disease Week, Gastrointestinal Cancers … Molecular detection of colorectal neoplasia. [Review] [107 refs]. … 2 f-dna.ti,ab.
3 sdna.ti,ab.
4 DNA/
5 DNA Methylation/
6 DNA Mutational Analysis/
7 DNA, Neoplasm … Colonic Polyps/
14 Colonic Neoplasms/
15 Sigmoid Neoplasms/
16 Rectal Neoplasms/
17 Anus Neoplasms